SCOPOLAMINE TRANSDE

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of one pouch of SCOPOLAMINE TRANSDE, identified by NSN 6505014562380 and NDC 68001-220-01, at a total value of $65.48. The order was issued on July 14, 2026, with a required delivery date of July 29, 2026, and is delivered FOB destination to Fort Campbell, KY, at the specified military installation address. The contractor is responsible for all transportation costs and risks until the item is received at the destination, where the government conducts final inspection and acceptance based on conformity to contract specifications. Packaging must use traceable shipping methods only, with parcel post strictly prohibited, and all packages and documentation must clearly display the master contract and delivery order numbers along with the manufacturer’s CAGE code and National Drug Code. The contractor holds certifications as a small business, small disadvantaged business, and women-owned business, triggering associated reporting and subcontracting obligations under federal programs. Payment will be processed by the Defense Finance and Accounting Service to the remittance address in Columbus, Ohio, and invoicing is expected to be submitted electronically through DLA systems, though the specific platform is not named. The contracting officer is Lisa Quinn, with Shairy M. Cartagena serving as the local administrative contact. No contract clauses, attachments, evaluation factors, or MIL-STD packaging standards are explicitly referenced in the documentation, and the order reflects a low-dollar, single-line-item transaction with zero variance allowed in quantity. The item is subject to standard quality certification and requires no special security, key personnel, or contractual options.